Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Senzime AB ( (SE:SEZI) ) has shared an announcement.
Senzime AB has announced a webcast presentation of its second quarter 2025 financial report, scheduled for July 18. The presentation, led by CEO Philip Siberg, will provide insights into the company’s performance and will include a Q&A session, reflecting Senzime’s commitment to transparency and engagement with investors and stakeholders.
More about Senzime AB
Senzime is a leading medical device company established in 1999, specializing in precision-based monitoring systems that enhance perioperative patient safety, reduce costs, and improve outcomes. Their flagship product, the TetraGraph® system, is widely used in operating rooms worldwide for accurate neuromuscular transmission monitoring during surgery. Headquartered in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market and cross-traded on the US OTCQX Market.
Average Trading Volume: 321,021
Current Market Cap: SEK843.6M
Find detailed analytics on SEZI stock on TipRanks’ Stock Analysis page.